| Financial Year |
March 31 2023 |
| Monetary Funds |
1,826,690,467.23 |
| Held-for-trading Financial Assets |
534,600.00 |
| Notes Receivable |
300,000.00 |
| Accounts Receivable |
128,881,620.81 |
| Advances to Suppliers |
72,776,953.19 |
| Other Receivables |
537,547.46 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
293,296,272.62 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
414,940,891.12 |
| Total Current Assets |
3,274,995,547.34 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
360,156.33 |
| Fixed Assetes |
1,017,477,500.21 |
| Under-construction Projects |
2,126,343.65 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
447,530,225.55 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
139,660.36 |
| Deferred Income Tax Assets |
41,412,790.05 |
| Other Non-Current Assets |
30,330,046.36 |
| Sub-Total of Non-Current Assets |
1,578,536,722.51 |
| Total Assets |
4,853,532,269.85 |
| Short-Term Loans |
700,000,000.00 |
| Trading Financial liabilities |
582,000.00 |
| Notes Payable |
14,221,721.58 |
| Accounts Payable |
314,898,506.66 |
| Accounts Received In Advance |
41,834.86 |
| Employee Compensation Payable |
10,948,510.46 |
| Taxes Payable |
926,486.70 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
25,194,463.91 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
200,117,777.78 |
| Other Current Liabilities |
-- |
| Sub-Total of Current Liabilities |
1,267,200,962.09 |
| Long-term Loans |
200,187,499.99 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
1,398,856.71 |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
276,002,178.97 |
| Total Liabilities |
1,543,203,141.06 |
| Paid-In Capital(Or Share Stock) |
281,719,277.00 |
| Capital Surplus |
2,136,526,485.78 |
| Surplus Reserve |
80,045,706.40 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
812,532,673.87 |
| Minority Stockholder's Interest |
151,003.09 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
3,310,178,125.70 |
| Owner's Equity（Stockholder's Equity） |
3,310,329,128.79 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
4,853,532,269.85 |
